
zzso complications are among the most common causes of death in cancer patients and result in considerable reduction in quality of life in patients zzso Besides zzso zzso interventions such as surgery, chemotherapy and zzso of an zzso central zzso line have been identified as additional risk factors for zzso While zzso prophylaxis is recommended, zzso in presence of other risk factors, especially concerning cost-benefit ratio, is still a matter of zzso zzso of genetic risk factors for zzso may add in the near future to the decision-making process to provide cancer patients with zzso zzso With the introduction of low molecular weight zzso to clinical practice clinicians now face an alternative option to oral zzso for long-term therapy and zzso zzso evidence that low molecular weight zzso reduce mortality of cancer patients independent of cardiovascular causes have zzso intensive clinical efforts to zzso zzso in cancer zzso 

